Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,501.50
-1.80 (-0.12%)
Nov 6, 2025, 3:29 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.21 trillion as of November 6, 2025. Its market cap has decreased by -3.75% in one year.
Market Cap
1.21T
Enterprise Value
1.11T
Revenue
279.66B
Ranking
n/a
PE Ratio
22.33
Stock Price
1,501.50
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.21T, an increase of 80,121.48%. That is a compound annual growth rate of 25.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 1.21T | -1.66% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | 661.25B | 71.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.81T |
| Apollo Hospitals Enterprise | 1.12T |
| Mankind Pharma | 978.03B |
| Zydus Lifesciences | 977.76B |
| Fortis Healthcare | 769.38B |
| Alkem Laboratories | 672.97B |
| Aurobindo Pharma | 667.40B |